STABILE, ARMANDO
 Distribuzione geografica
Continente #
EU - Europa 1.955
AS - Asia 1.011
NA - Nord America 838
SA - Sud America 220
AF - Africa 20
OC - Oceania 2
Totale 4.046
Nazione #
IT - Italia 1.365
US - Stati Uniti d'America 798
SG - Singapore 320
CN - Cina 315
BR - Brasile 171
HK - Hong Kong 138
SE - Svezia 135
NL - Olanda 118
JP - Giappone 100
DE - Germania 66
VN - Vietnam 62
RU - Federazione Russa 50
FI - Finlandia 46
TR - Turchia 34
FR - Francia 30
GB - Regno Unito 29
CA - Canada 27
AR - Argentina 24
IN - India 21
PL - Polonia 19
ES - Italia 18
AT - Austria 13
CZ - Repubblica Ceca 11
LT - Lituania 11
MX - Messico 11
CO - Colombia 9
ZA - Sudafrica 7
IE - Irlanda 6
NO - Norvegia 6
CH - Svizzera 5
DK - Danimarca 5
UA - Ucraina 5
BE - Belgio 4
DZ - Algeria 4
MA - Marocco 4
BD - Bangladesh 3
EC - Ecuador 3
GR - Grecia 3
PE - Perù 3
PH - Filippine 3
PY - Paraguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CL - Cile 2
ID - Indonesia 2
IR - Iran 2
KE - Kenya 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BB - Barbados 1
BJ - Benin 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SI - Slovenia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 4.046
Città #
Milan 233
Singapore 197
Hong Kong 134
Ashburn 114
Rome 105
New York 102
Dallas 86
Shanghai 77
Beijing 62
Turin 45
Hefei 43
Los Angeles 37
Lawrence 29
Princeton 29
Verona 27
Bologna 26
Florence 25
Tokyo 25
Boardman 24
Munich 23
Ho Chi Minh City 22
Genoa 21
São Paulo 21
Helsinki 20
Bari 19
Moscow 19
Palermo 19
Naples 18
Turku 17
Brooklyn 16
Hanoi 16
Montreal 13
Warsaw 13
Brescia 12
Santa Clara 12
Azzano San Paolo 11
Frankfurt am Main 11
Nuremberg 11
Bolzano 10
Catania 10
Chennai 10
Chicago 10
Guangzhou 10
Stockholm 10
Trieste 10
London 9
Ankara 8
Atlanta 8
Amsterdam 7
Bergamo 7
Bursa 7
Falconara Marittima 7
Istanbul 7
Lamezia Terme 7
Modena 7
Padova 7
Paris 7
Vienna 7
Cesano Boscone 6
Columbus 6
Denver 6
Dublin 6
Hayamiya 6
Houston 6
Manchester 6
Montepulciano 6
Parma 6
Phoenix 6
Porto Alegre 6
The Dalles 6
Venice 6
Andria 5
Charleston 5
Da Nang 5
Johannesburg 5
Lappeenranta 5
Pavia 5
Prato 5
Pune 5
Toronto 5
Treviso 5
Valencia 5
Arcore 4
Brussels 4
Cerano 4
Council Bluffs 4
Mexico City 4
Miami 4
Mumbai 4
Novara 4
Orem 4
Oslo 4
Passo Fundo 4
Pisa 4
Rio de Janeiro 4
San Francisco 4
Trento 4
Vicenza 4
's-Hertogenbosch 3
Aarhus 3
Totale 2.102
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.614
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 106
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 89
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 78
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 76
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 74
Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study 73
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 70
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 70
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 70
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 68
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 67
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 65
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies 64
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 63
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1 63
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 61
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 61
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 59
Reply by Authors 58
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 55
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 55
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 54
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 54
The quality of life of children and adolescents with X-linked agammaglobulinemia 51
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 51
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 51
Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis 51
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation 50
Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy 49
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 49
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 48
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter 47
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 47
Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer 45
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society 45
RE: Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates 45
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter 41
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 41
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy 37
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 36
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment 36
The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series 34
Letter - Can micro-ultrasound be the new first-choice test for patients with a suspicion of prostate cancer? 34
Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes 31
Radioguided Surgery for Prostate Cancer 29
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 10
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging 8
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history 7
Global Variation in Magnetic Resonance Imaging Quality of the Prostate 4
null 1
null 1
Totale 4.146
Categoria #
all - tutte 19.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 6 0 0 1 0 0 0
2021/2022114 0 12 4 8 8 7 15 14 5 10 17 14
2022/2023346 78 57 22 14 14 55 24 26 15 4 24 13
2023/2024686 12 16 37 47 50 131 43 77 11 80 78 104
2024/20251.550 186 70 119 73 105 145 207 185 165 87 91 117
2025/20261.437 252 189 155 458 355 28 0 0 0 0 0 0
Totale 4.146